Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics
|
December 3, 2003
Mean hepatic recovery ratio in capacity-limited first-pass effect by three-point sampling method
Mitsuo Higashimori, Kiyoshi Yamaoka
Journal of Pharmaceutical Sciences
|
April 3, 2020
Physiologically Based Pharmacokinetic Modelling of Glycopyrronium in Patients With Renal Impairment
Mitsuo Higashimori, Kensuke Ishikawa, Michael Gillen, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
October 29, 2019
Physiologically based pharmacokinetic modeling to predict exposures in healthy Japanese subjects with different CYP2C19 phenotypes: Esomeprazole case study
Mitsuo Higashimori, Hitoshi Shimada, Katsuomi Ichikawa, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
January 3, 2023
[Andexanet alfa (ONDEXXYA<sup>®</sup> for Intravenous Injection 200 mg), a reversal agent for direct factor Xa inhibitors: pharmacological characteristics and clinical evidence]
Toshitaka Yajima, Mitsuo Higashimori, Chie Takata, et al.
Pharmaceutical Statistics
|
August 27, 2019
Optimal designs for regional bridging studies using the Bayesian power prior method
Mario Nagase, Shinya Ueda, Mitsuo Higashimori, et al.
Molecular Pharmaceutics
|
December 20, 2022
Prediction of the Contribution Ratio of a Target Metabolic Enzyme to Clearance from Chemical Structure Information
Reiko Watanabe, Toshio Kawata, Shinya Ueda, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 4, 2019
Assessing pharmacokinetic differences in Caucasian and East Asian (Japanese, Chinese and Korean) populations driven by CYP2C19 polymorphism using physiologically-based pharmacokinetic modelling
Li Zhou, Pradeep Sharma, Karen Rowland Yeo, et al.
Cancer Chemotherapy and Pharmacology
|
February 15, 2019
Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer
Toshio Kawata, Mitsuo Higashimori, Yohji Itoh, et al.
Clinical Pharmacology and Therapeutics
|
February 26, 2019
Oncology Therapy Drugs in China, Japan, and the United States: Pharmacokinetic Characteristics, Dose Regimens, and Development Strategies
Li Zhou, Mitsuo Higashimori, Kai Shen, et al.
Clinical Pharmacology in Drug Development
|
November 27, 2021
Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials?
Masaru Hirano, Masanori Yamada, Toshiaki Tanaka, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Pharmacokinetics and Pharmacodynamics
|
December 3, 2003
Mean hepatic recovery ratio in capacity-limited first-pass effect by three-point sampling method
Mitsuo Higashimori, Kiyoshi Yamaoka
Journal of Pharmaceutical Sciences
|
April 3, 2020
Physiologically Based Pharmacokinetic Modelling of Glycopyrronium in Patients With Renal Impairment
Mitsuo Higashimori, Kensuke Ishikawa, Michael Gillen, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
October 29, 2019
Physiologically based pharmacokinetic modeling to predict exposures in healthy Japanese subjects with different CYP2C19 phenotypes: Esomeprazole case study
Mitsuo Higashimori, Hitoshi Shimada, Katsuomi Ichikawa, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
January 3, 2023
[Andexanet alfa (ONDEXXYA<sup>®</sup> for Intravenous Injection 200 mg), a reversal agent for direct factor Xa inhibitors: pharmacological characteristics and clinical evidence]
Toshitaka Yajima, Mitsuo Higashimori, Chie Takata, et al.
Pharmaceutical Statistics
|
August 27, 2019
Optimal designs for regional bridging studies using the Bayesian power prior method
Mario Nagase, Shinya Ueda, Mitsuo Higashimori, et al.
Molecular Pharmaceutics
|
December 20, 2022
Prediction of the Contribution Ratio of a Target Metabolic Enzyme to Clearance from Chemical Structure Information
Reiko Watanabe, Toshio Kawata, Shinya Ueda, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 4, 2019
Assessing pharmacokinetic differences in Caucasian and East Asian (Japanese, Chinese and Korean) populations driven by CYP2C19 polymorphism using physiologically-based pharmacokinetic modelling
Li Zhou, Pradeep Sharma, Karen Rowland Yeo, et al.
Cancer Chemotherapy and Pharmacology
|
February 15, 2019
Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer
Toshio Kawata, Mitsuo Higashimori, Yohji Itoh, et al.
Clinical Pharmacology and Therapeutics
|
February 26, 2019
Oncology Therapy Drugs in China, Japan, and the United States: Pharmacokinetic Characteristics, Dose Regimens, and Development Strategies
Li Zhou, Mitsuo Higashimori, Kai Shen, et al.
Clinical Pharmacology in Drug Development
|
November 27, 2021
Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials?
Masaru Hirano, Masanori Yamada, Toshiaki Tanaka, et al.
Page
of 2